| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |